HIGHOutside partySupplier
single-source silicone supplier
“10-K Item 1A: 'We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants.'”
ESTA · Concentration risk · 10-K extracted
Establishment Labs Holdings (ESTA) concentration risks
Updated
The most significant concentration Establishment Labs Holdings discloses is single-source silicone supplier, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Establishment Labs Holdings’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 2 disclosed concentrations
HIGH1
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMBuilt-in & outside partyProduct / Revenue mix
Motiva Implants
“10-K Item 1: 'the majority of our revenue has been generated from sales of our Motiva Implants'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-06-24The company's concentration profile combines a high-share supplier dependency with a moderate product concentration, both of which are load-bearing for the viability of the commercial business. The most acute exposure is a supply chain dependency: the company relies on a single-source, third-party supplier for medical-grade long-term implantable silicone, the primary raw material used in its Motiva Implants. This is a high-share dependency with no disclosed alternative source — any disruption at the sole silicone supplier due to regulatory action, manufacturing failure, or a breakdown in the commercial relationship could halt production of the company's core product with no near-term substitute. The product concentration reinforces this vulnerability: the majority of revenue has been generated from sales of Motiva Implants — a moderate-share mixed exposure that reflects both the deliberate product-line focus of the company and a dependency on continued market acceptance, regulatory clearances in target geographies, and competitive positioning of that single product family. The two exposures compound each other in a meaningful way: the company's revenue base is concentrated in a single product line whose entire production depends on a sole-source raw material supplier. A disruption in either the supply chain or the product's regulatory or commercial standing would affect substantially all of the company's revenue. On balance, the sole-source silicone supplier relationship is the most idiosyncratic and operationally critical risk in the disclosed profile, and it warrants close monitoring as a potential single point of failure.
For the engine’s reasoning on ESTA’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ESTA● | Establishment Labs Holdings Inc | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
| BIO | Bio-Rad Laboratories, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.